Search results for "OUTCOME"

showing 10 items of 5148 documents

Long-term outcome after urinary diversion using the ileocecal segment in children and adolescents: Complications of the efferent segment.

2016

Long-term outcomes are of special concern in children after urinary diversion. In a single institution study we evaluated retrospectively the long-term outcomes of urinary diversion in children, in whom the ileocecal segment had been used, in respect to complications of the efferent segment.The Mainz pouch was used in 107 children for continent urinary diversion. Indications were neurogenic bladder (53%, 57/107), exstrophy-epispadias complex (25%, 27/107), malignancy (13%, 14/107), and others (9%, 9/107). Continent cutaneous diversion was performed in 95 patients, and 12 patients received bladder augmentation/substitution with a continent cutaneous stoma. As efferent segment, we used the in…

medicine.medical_specialtyTime FactorsAdolescentUrologymedicine.medical_treatmentUrinary Bladder030232 urology & nephrologyConstriction PathologicUrinary Diversiondigestive system03 medical and health sciences0302 clinical medicinePostoperative ComplicationsStoma (medicine)IleummedicineHumansChildCecumRetrospective Studiesbusiness.industryUrinary diversionUrinary Bladder DiseasesSurgical Stomasmedicine.diseaseAppendixSurgeryStenosismedicine.anatomical_structureTreatment OutcomeBladder augmentation030220 oncology & carcinogenesisChild PreschoolPediatrics Perinatology and Child HealthPouchComplicationbusinessContinent Urinary DiversionJournal of pediatric urology
researchProduct

The timing of introduction of pharmaceutical innovations in seven European countries

2014

RATIONALE, AIMS AND OBJECTIVES: Differences in the performance of medical care may be due to variation in the introduction and diffusion of medical innovations. The objective of this paper is to compare seven European countries (United Kingdom, the Netherlands, West Germany, France, Spain, Estonia and Sweden) with regard to the year of introduction of six specific pharmaceutical innovations (antiretroviral drugs, cimetidine, tamoxifen, cisplatin, oxalaplatin and cyclosporin) that may have had important population health impacts. METHODS: We collected information on introduction and further diffusion of drugs using searches in the national and international literature, and questionnaires to …

medicine.medical_specialtyTime FactorsAlternative medicinePopulation healthpharmaceuticalsMedical careWest germanyoutcome measuresNursingquality of careSurveys and QuestionnairesInternational literaturemedicineHumansPharmaceutical innovationsSales statisticsDrug ApprovalQuality of Health Carebusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthOriginal ArticlesmortalityClinical trialEuropePharmaceutical Preparationsmedical careDiffusion of Innovationbusinesshealth systemsDemographyJournal of Evaluation in Clinical Practice
researchProduct

Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Mod…

2010

The aim of this study is to assess the long-term effect of mesenchymal stem cells (MSC) transplantation in a rat model of chronic myocardial infarction (MI) in comparison with the effect of bone marrow mononuclear cells (BM-MNC) transplant. Five weeks after induction of MI, rats were allocated to receive intramyocardial injection of 106 GFP-expressing cells (BM-MNC or MSC) or medium as control. Heart function (echocardiography and 18F-FDG-microPET) and histological studies were performed 3 months after transplantation and cell fate was analyzed along the experiment (1 and 2 weeks and 1 and 3 months). The main findings of this study were that both BM-derived populations, BM-MNC and MSC, ind…

medicine.medical_specialtyTime FactorsAngiogenesisMyocardial InfarctionBiomedical Engineeringlcsh:Medicine030204 cardiovascular system & hematologyMesenchymal Stem Cell TransplantationPeripheral blood mononuclear cellTimeRats Sprague-DawleyAndrology03 medical and health sciences0302 clinical medicineInternal medicinemedicineAnimalsRegenerationChronic myocardial infarctionCells CulturedCardiac remodelingBone Marrow Transplantation030304 developmental biologyStem cell transplantation for articular cartilage repair0303 health sciencesTransplantationBone marrow stem cellsVentricular Remodelingbusiness.industryMyocardiumlcsh:RMesenchymal stem cellBone Marrow Stem CellCell BiologyRatsEndothelial stem cellTransplantationDisease Models AnimalTreatment Outcomemedicine.anatomical_structureChronic DiseaseCardiologyFemaleAngiogenesisBone marrowbusinessCell Transplantation
researchProduct

Acute aortic dissection

2011

An acute aortic syndrome with simultaneous presence of a penetrating aortic ulcer, an intramural haematoma, a thoracic aortic dissection and an abdominal aortic aneurysm rupture has not previously been reported. Herein, we describe our experience with a patient treated by endovascular means with an 8-year follow-up.

medicine.medical_specialtyTime FactorsAortic RuptureAortic Diseases610 Medicine & healthAortographySettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationInternal medicinemedicineHumanscardiovascular diseasesAortic ruptureUlcerAged 80 and overAcute aortic syndromeAortic dissectionHematomaAortic Aneurysm Thoracic10042 Clinic for Diagnostic and Interventional Radiologybusiness.industryEndovascular ProceduresSyndromeGeneral Medicinemedicine.diseaseAbdominal aortic aneurysm10020 Clinic for Cardiac SurgerySurgeryIntramural haematomaAortic DissectionTreatment Outcomeacute aortic dissection syndromeAcute Diseasecardiovascular systemCardiologyThoracic aortic dissectionFemaleTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalJournal of Cardiovascular Medicine
researchProduct

Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-anal…

2019

Background & Aims: Risk for relapse after induction of remission with steroid therapy has been studied extensively in patients with autoimmune pancreatitis (AIP), but findings have been equivocal. We performed a systematic review and meta-analysis to estimate the relapse rate of AIP after initial remission after steroid treatment and to identify factors associated with relapse. Methods: Three reviewers searched MEDLINE, SCOPUS, and EMBASE until July 2018 to identify studies on rate of relapse of AIP after induction of remission with steroid therapy. A pooled estimate was calculated using the DerSimonian and Laird method for a random-effects model. This study was conducted in accordance …

medicine.medical_specialtyTime FactorsAutoimmune Pancreatitismedicine.medical_treatmentMEDLINEInflammation; Long-Term Outcome; Pancreas; Response To TreatmentSteroidlaw.invention03 medical and health sciences0302 clinical medicineMaintenance therapyRandomized controlled trialRecurrenceRisk FactorslawInternal medicinemedicineHumansPancreaIn patientGlucocorticoidsPancreasAutoimmune pancreatitisInflammationHepatologybusiness.industryRemission InductionResponse To TreatmentGastroenterologyLong-Term Outcomemedicine.diseaseSystematic review030220 oncology & carcinogenesisMeta-analysisChronic Disease030211 gastroenterology & hepatologybusinessFollow-Up StudiesClinical Gastroenterology and Hepatology
researchProduct

Video-assisted two-stage basilic vein transposition for creation of brachio-basilic arteriovenous fistulae

2012

We report our experience in a mixed minimally-in- vasive technique for the two-stage transposition of basilic vein on a small series of eight patients. The operative tech- nique consisted of a modified endoscopic (1) approach for the two-stage transposition (2). The intervention was performed under Brachial Plexus Block (3).

medicine.medical_specialtyTime FactorsBasilic VeinTreatment outcomeOperative TimeArteriovenous fistula; End Stage Renal Disease; Video-assisted surgeryVideo-assisted surgerySettore MED/22 - Chirurgia VascolareSurgical methodsVeinsTransposition (music)Upper ExtremityArteriovenous Shunt SurgicalRenal DialysismedicineHumansVideo assistedVascular PatencyArteriovenous fistulabusiness.industryEndoscopyBrachial Plexus BlockSurgerySettore MED/18 - Chirurgia GeneraleTreatment OutcomeSurgery Computer-AssistedNephrologyOperative timeSurgeryEnd Stage Renal Diseasebusiness
researchProduct

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

2010

Resection of intact primary tumor is controversial in metastatic breast cancer patients. The aim of this study is to review the impact of surgical resection of primary tumor on overall survival and to assess the role of timing of surgery on survival rates.208 patients with metastatic breast cancer diagnosed between 1982 and 2005 in the Hospital Clinico of Valencia (Spain) were analysed. Exclusion criteria were age80, PS 3-4, Charlson score 3 or follow-up90 days. 123 of these underwent surgery and 85 did not. In order to assess the role of timing, the "surgery" cohort was divided into two sub-groups: "before" (n = 78) or "after" (n = 45) diagnosis of disseminated disease.In the surgery group…

medicine.medical_specialtyTime FactorsBreast surgerymedicine.medical_treatmentBreast NeoplasmsmedicineHumansNeoplasm MetastasisMastectomySurvival analysisNeoplasm StagingRetrospective StudiesUnivariate analysisPerformance statusbusiness.industryCarcinoma Ductal BreastGeneral MedicineMiddle Agedmedicine.diseaseDebulkingSurvival AnalysisPrimary tumorMetastatic breast cancerSurgeryCarcinoma LobularTreatment OutcomeSpainFemaleSurgerybusinessMastectomyThe Breast
researchProduct

RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) Study: Myocardial Dysfunction, Postoperative Neurocognitive Dysfunction, and 1 Year Foll…

2018

Background Remote ischemic preconditioning ( RIPC ) has been suggested to protect against certain forms of organ injury after cardiac surgery. Previously, we reported the main results of RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) Study, a multicenter trial randomizing 1403 cardiac surgery patients receiving either RIPC or sham‐ RIPC . Methods and Results In this follow‐up paper, we present 1‐year follow‐up of the composite primary end point and its individual components (all‐cause mortality, myocardial infarction, stroke and acute renal failure), in a sub‐group of patients, intraoperative myocardial dysfunction assessed by transesophageal echocardiography and the incidenc…

medicine.medical_specialtyTime FactorsMyocardial InfarctionNeurocognitive DisordersMyocardial Reperfusion InjuryNeuropsychological Tests030204 cardiovascular system & hematologyischemia/reperfusion injuryRisk Assessment03 medical and health sciencesCognition0302 clinical medicineDouble-Blind MethodRisk FactorsIschemiaGermanyMulticenter trialClinical StudiesClinical endpointHumansMedicineProspective Studies030212 general & internal medicineMyocardial infarctionCardiac Surgical ProceduresProspective cohort studyPropofolStrokeOriginal ResearchCardiovascular Surgerycardio‐vascular surgerybusiness.industryIncidenceProtective Factorsmedicine.diseaseSurgeryCardiac surgeryTreatment OutcomeIschemic Preconditioning MyocardialIschemic preconditioningremote ischemic preconditioningCardiology and Cardiovascular MedicinebusinessPropofolAnesthetics IntravenousEchocardiography Transesophagealmedicine.drug
researchProduct

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-i…

2022

Summary Background Vancomycin is the most widely used antibiotic for neonatal Gram-positive sepsis, but clinical outcome data of dosing strategies are scarce. The NeoVanc programme comprised extensive preclinical studies to inform a randomised controlled trial to assess optimised vancomycin dosing. We compared the efficacy of an optimised regimen to a standard regimen in infants with late onset sepsis that was known or suspected to be caused by Gram-positive microorganisms. Methods NeoVanc was an open-label, multicentre, phase 2b, parallel-group, randomised, non-inferiority trial comparing the efficacy and toxicity of an optimised regimen of vancomycin to a standard regimen in infants aged …

medicine.medical_specialtyTime FactorsPopulationEquivalence Trials as TopicLoading doseArticlelaw.inventionGram-positiveRandomized controlled triallawVancomycinIntensive careInternal medicineIntensive Care Units NeonatalSepsisDevelopmental and Educational PsychologyClinical endpointMedicineHumansDosingeducationInfusions Intravenouseducation.field_of_studybusiness.industryInfant NewbornInfantdosingUnited KingdomAnti-Bacterial AgentsEuropeRegimenTreatment OutcomeSpainRelative riskPediatrics Perinatology and Child Healthsepsibusiness
researchProduct

Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Stud…

2013

Primary aldosteronism (PA) is the most common endocrine form of hypertension and may carry an increased risk of atrial flutter or fibrillation (AFF). The primary goal of this multicentre cohort study is thus to prospectively establish the prevalence of PA in consecutive hypertensive patients referred for lone (non-valvular), paroxysmal or permanent AFF. Secondary objectives are to determine: (1) the predictors of AFF in patients with PA; (2) the rate of AFF recurrence at follow-up after specific treatment in the patients with PA; (3) the effect of AFF that can increase atrial natriuretic peptide via the atrial stretch and thereby blunt aldosterone secretion, on the aldosterone-to-renin rati…

medicine.medical_specialtyTime FactorsTime FactorElectric CountershockPlasma renin activityaldosteronism; atrial fibrillation; high blood pressure; plasma reninPrimary aldosteronismRecurrenceInternal medicineatraial fibrillationReninHyperaldosteronismInternal MedicinePrevalenceMedicineHumansSinus rhythmatrial fibrillationprimary aldosteronism; hypertension; atraial fibrillationProspective StudiesProspective cohort studyAldosteroneFibrillationaldosteronismprimary aldosteronismChi-Square Distributionbusiness.industryAtrial fibrillationmedicine.diseaseHyperaldosteronismplasma reninEuropeProspective StudieTreatment OutcomeAtrial FlutterResearch DesignAnti-Arrhythmia AgentBiological MarkerHypertensionCardiologyQuality of Lifemedicine.symptombusinessAnti-Arrhythmia AgentsAtrial flutterBiomarkersHumanhigh blood pressure
researchProduct